Common Variable Immune Deficiency: Why IVIG Is a Lifeline
CVID leaves the body without enough working antibodies to fight infection. Regular IVIG infusions replace what's missing and meaningfully cut down on illness.
What is CVID?
Common variable immune deficiency (CVID) is one of the most frequently diagnosed primary immunodeficiencies, a condition in which the immune system doesn't produce enough antibodies (immunoglobulins) to fight off infections effectively. It can be diagnosed at any age, though it's most often caught in adulthood.
People with CVID tend to get frequent, sometimes severe infections, particularly of the sinuses, lungs, and digestive tract, and may also be at higher risk for autoimmune conditions and certain complications if left untreated.
How infusion therapy helps
IVIG replaces the antibodies the body isn't making enough of on its own, giving the immune system the tools it needs to fight infections effectively. For most patients with CVID, this is not a temporary treatment but an ongoing, typically lifelong therapy.
Regular infusions, usually every three to four weeks, have been shown to significantly reduce the frequency and severity of infections, which is often the single biggest improvement in quality of life for patients with CVID.
Diagnosed with CVID?
Consistent IVIG therapy can dramatically reduce infections. Our physician-led team makes ongoing treatment straightforward.
Call (551) 336-5580This article is for general educational purposes and is not a substitute for medical advice. Treatment decisions should always be made with your physician based on your individual diagnosis and health history.